EBITDA: Income before interest, taxes, depreciation and amortization.
Cryo-Cell International Inc. (CCEL) had EBITDA of $2.53M for the most recently reported fiscal quarter, ending 2026-08-31.
| Income Statement Financials | |
$7.82M |
|
$1.27M |
|
$1.61M |
|
$6.21M |
|
$5.63M |
|
$2.19M |
|
$-0.37M |
|
$1.83M |
|
$1.76M |
|
$1.27M |
|
$1.27M |
|
$1.27M |
|
$1.18M |
|
$2.19M |
|
|
EBITDA |
$2.53M |
8.06M |
|
8.07M |
|
$0.16 |
|
$0.16 |
|
| Balance Sheet Financials | |
$13.17M |
|
$20.54M |
|
$49.13M |
|
$62.30M |
|
$15.33M |
|
$8.04M |
|
$63.37M |
|
$78.70M |
|
$-16.39M |
|
$-19.17M |
|
$-16.39M |
|
8.06M |
|
| Cash Flow Statement Financials | |
$3.64M |
|
$-0.13M |
|
$-2.41M |
|
$0.32M |
|
$1.43M |
|
$1.11M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
-0.96 |
|
-0.50 |
|
79.38% |
|
28.04% |
|
28.04% |
|
-- |
|
23.33% |
|
16.24% |
|
$3.44M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
3.02 |
|
1.14 |
|
78.61 |
|
-7.75% |
|
-6.63% |
|
2.04% |
|
-15.21% |
|
$-2.03 |
|
$0.43 |
|
$0.45 |
|